Wilmington, United States
- Biotechnology
- Health Tech
- Life Sciences
- Pharma
About
Ascenta Capital focuses on advancing biotech companies through Phase 1 and Phase 2 clinical development. The firm provides strategic capital and operational support to help high-potential therapeutics reach key inflection points and prepare for later-stage partnerships or exits.
Ascenta Capital invests in development-stage biotechnology companies with strong clinical potential in the United States.
The leadership team has over 15 years of experience in biotech venture capital and corporate finance, with a focus on clinical-stage investments and value creation through science-driven companies.
Ascenta Capital Contacts Information